Drug profile

The FDA adverse-event record for Bordetella Bronchiseptica 92B 012992-7 Strain Boehringer Ingelheim;Canine Adenov

Name: Bordetella Bronchiseptica 92B 012992-7 Strain Boehringer Ingelheim;Canine Adenov - FDA Animal Adverse Event Reports
Creator: PlainBreed
License: https://creativecommons.org/publicdomain/zero/1.0/

418 FDA reports name Bordetella Bronchiseptica 92B 012992-7 Strain Boehringer Ingelheim;Canine Adenov, a high-volume drug in the CVM extract. Species, reactions, and outcomes follow.

#346 of 2,679
by report volume (all drugs): 418
adverse-event reports: 7.2%
death-coded share: Dog
most-reported species

Compiled by PlainBreed

Verify with FDA CVM →

Corpus placement

According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Bordetella Bronchiseptica 92B 012992-7 Strain Boehringer Ingelheim;Canine Adenov ranks #346 of 2679 by total reports (418) and #686 of 1130 by death-coded share (7.2%). National dual: Milbemycin Oxime + Spinosad is #1 of 2679 drugs by total adverse-event reports (149,624) at death-coded-share rank 965 of 1130 drugs with at least 50 reports (2.3%); separately, Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A-Locus In The Eo-1A Lineage) is #1 highest death-coded share at 97.8% (report rank #821).

149,624
Milbemycin Oxime + Spinosad reports (#1): 97.8%
Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A-Locus In The Eo-1A Lineage) death share (#1): #346
This drug, reports of 2679: #686
This drug, death share of 1130

Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Bordetella Bronchiseptica 92B 012992-7 Strain Boehringer Ingelheim;Canine Adenov has 418 reports now versus 405 in that prior snapshot: 13 more (3.2%).

Report change: +13
Death-coded reports: +1
Death-coded share: +0.0 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Bordetella Bronchiseptica 92B 012992-7 Strain Boehringer Ingelheim;Canine Adenov changes

Signature read: 418 reports place Bordetella Bronchiseptica 92B 012992-7 Strain Boehringer Ingelheim;Canine Adenov in the upper third of FDA AER volume (#346 of 2,679).

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

418

Total Reports

Deaths Reported

7.2%

Death-coded share of reports

Active Ingredients

Bordetella Bronchiseptica 92B 012992-7 Strain Boehringer Ingelheim;Canine Adenov

Administration Routes

NasalSubcutaneousOralSubconjunctival

Species Affected

Dog 418

Most Affected Breeds

Retriever - Labrador 39

Chihuahua 30

Retriever - Golden 30

Terrier - Bull - American Pit 22

Terrier - Yorkshire 21

Shih Tzu 15

Crossbred Canine/dog 14

Bulldog - French 12

Boxer (German Boxer) 11

Shepherd Dog - Australian 11

Most Reported Reactions

Vomiting 161

Anaphylaxis 69

Lethargy (see also Central nervous system depression in 'Neurological') 54

Lethargy (see also Central nervous system depression in Neurological) 53

Facial swelling (see also 'Skin') 50

Diarrhoea 47

Pale mucous membrane 43

Hives (see also 'Skin') 42

Lack of efficacy - NOS 29

Fever 28

Facial swelling (see also Skin) 28

Decreased appetite 23

Outcome Breakdown

Ongoing

219 (52.4%)

Recovered/Normal

155 (37.1%)

Died

16 (3.8%)

Euthanized

14 (3.3%)

Outcome Unknown

14 (3.3%)

Bordetella Bronchiseptica 92B 012992-7 Strain Boehringer Ingelheim;Canine Adenov: high report volume in the FDA AER row

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

High-volume nationwide drug peers

Two openFDA-derived peer sets for Bordetella Bronchiseptica 92B 012992-7 Strain Boehringer Ingelheim;Canine Adenov, both floored at ≥50 reports so the neighborhoods stay in the advertised mass.

Similar report volume

Nearest other drugs by FDA report count (418 here).

Fipronil 9.8%/S-Methoprene 8.8%/ Amitraz 22.1% Spot-On 419 Dhpp Vaccine 421 Omeprazole 37% Oral Paste 415 Fluid Therapy (Unknown) 422

Similar death-coded share

Nearest other drugs by death-coded share (7.2% here), distinct from the volume row.

Velagliflozin Proline Monohydrate 7.2% Canine Adenovirus Type 2-Parainfluenza-Bordetella Bronchiseptica Vaccine, Modified Live Virus, Avirulent Live Culture 7.2% Oclacitinib 7.2% Eye Medication (Unknown) 7.1%

What to do with this drug

Compare Bordetella Bronchiseptica 92B 012992-7 Strain Boehringer Ingelheim;Canine Adenov's report volume and death-coded share against similar drugs nationwide. See similar drugs
Read how death-coded share differs from a mortality rate before drawing conclusions. Understanding adverse events
Browse the full drug directory to compare report counts across products. All drugs

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Bordetella Bronchiseptica 92B 012992-7 Strain Boehringer Ingelheim;Canine Adenov (#346 of 2,679 by report volume); death-coded 7.2%. PlainBreed drug row · report volume stamp 418 · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →